0001209191-12-046401.txt : 20120921 0001209191-12-046401.hdr.sgml : 20120921 20120921162557 ACCESSION NUMBER: 0001209191-12-046401 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120919 FILED AS OF DATE: 20120921 DATE AS OF CHANGE: 20120921 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139-4242 BUSINESS PHONE: 6165776000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kelly Lisa CENTRAL INDEX KEY: 0001349077 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 121104466 MAIL ADDRESS: STREET 1: 125 SPRING STREET CITY: LEXINGTON STATE: MA ZIP: 02421 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2012-09-19 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001349077 Kelly Lisa C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY ST. CAMBRIDGE MA 02139 0 1 0 0 SVP, Human Resources Common Stock 2012-09-19 4 M 0 954 32.16 A 18203 D Common Stock 2012-09-19 4 M 0 3093 33.00 A 21296 D Common Stock 2012-09-19 4 S 0 4047 57.61 D 17249 D Common Stock 1957 I 401(k) Employee Stock Option (right to buy) 32.16 2012-09-19 4 M 0 954 0.00 D 2018-07-23 Common Stock 954 0 D Employee Stock Option (right to buy) 33.00 2012-09-19 4 M 0 3093 0.00 D 2019-10-21 Common Stock 3093 56907 D Transaction made pursuant to Ms. Kelly-Croswell's company approved trading plan under Rule 10b5-1. Open market sales reported on this line occurred at a weighted average price of $57.61 (range $57.05 to $57.94). Ms. Kelly-Croswell undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Fully vested. Omar White, Attorney-In-Fact 2012-09-21